Qatari German Company for Medical Devices (Q.P.S.C.) (QSE:QGMD)
Qatar · Delayed Price · Currency is QAR 1.300
-0.004 (-0.31%)
Nov 12, 2026, 1:09 PM AST
QSE:QGMD Income Statement
Financials in millions QAR. Fiscal year is January - December.
Millions QAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.11 | 4.57 | 9.98 | 27.85 | 42.66 | 40.55 | |
Revenue Growth | 63.56% | -54.20% | -64.15% | -34.71% | 5.18% | 65.07% |
Cost of Revenue | 3.14 | 3.12 | 15.01 | 18.99 | 28.84 | 30.92 |
Gross Profit | 2.97 | 1.45 | -5.02 | 8.86 | 13.82 | 9.64 |
Selling, General & Admin | 2.71 | 3.06 | 5.17 | 4.62 | 5.84 | 10.35 |
Other Operating Expenses | -0.23 | - | - | - | - | -6.67 |
Operating Expenses | 8.64 | 9.21 | 55 | 9.96 | 11.26 | 3.68 |
Operating Income | -5.68 | -7.76 | -60.02 | -1.11 | 2.55 | 5.96 |
Interest Expense | -0.61 | -1.69 | -10.75 | -2.7 | -3.79 | -4.74 |
Currency Exchange Gain (Loss) | 0.02 | 0.02 | -0.04 | - | - | - |
Other Non Operating Income (Expenses) | 1.47 | 11.06 | 2.47 | 2.93 | 2.48 | -0.04 |
EBT Excluding Unusual Items | -4.79 | 1.63 | -68.34 | -0.88 | 1.24 | 1.18 |
Gain (Loss) on Sale of Assets | 0.06 | 0.06 | - | - | - | - |
Asset Writedown | -2 | -2 | -0.15 | 2.22 | - | - |
Other Unusual Items | 9.59 | 9.59 | - | - | - | - |
Pretax Income | 2.86 | 9.27 | -68.49 | 1.34 | 1.24 | 1.18 |
Net Income | 2.86 | 9.27 | -68.49 | 1.34 | 1.24 | 1.18 |
Net Income to Common | 2.86 | 9.27 | -68.49 | 1.34 | 1.24 | 1.18 |
Net Income Growth | - | - | - | 7.39% | 5.36% | 33.55% |
Shares Outstanding (Basic) | 118 | 116 | 116 | 116 | 116 | 116 |
Shares Outstanding (Diluted) | 118 | 116 | 116 | 116 | 116 | 116 |
Shares Change | 2.55% | - | - | - | - | - |
EPS (Basic) | 0.02 | 0.08 | -0.59 | 0.01 | 0.01 | 0.01 |
EPS (Diluted) | 0.02 | 0.08 | -0.59 | 0.01 | 0.01 | 0.01 |
EPS Growth | - | - | - | 7.38% | 5.36% | 33.55% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.27 | 1.32 | 1.02 | -2.03 | 0.8 | 5.21 |
Free Cash Flow Per Share | -0.00 | 0.01 | 0.01 | -0.02 | 0.01 | 0.04 |
Gross Margin | 48.55% | 31.80% | -50.30% | 31.81% | 32.39% | 23.77% |
Operating Margin | -92.92% | -169.70% | -601.11% | -3.97% | 5.98% | 14.70% |
Profit Margin | 46.75% | 202.82% | -685.92% | 4.80% | 2.92% | 2.91% |
Free Cash Flow Margin | -4.41% | 28.84% | 10.23% | -7.28% | 1.87% | 12.84% |
EBITDA | -1.17 | -3.25 | -55.49 | 4.24 | 7.97 | 11.37 |
EBITDA Margin | -19.21% | -71.08% | - | 15.22% | 18.69% | 28.03% |
D&A For EBITDA | 4.5 | 4.51 | 4.53 | 5.34 | 5.42 | 5.4 |
EBIT | -5.68 | -7.76 | -60.02 | -1.11 | 2.55 | 5.96 |
EBIT Margin | -92.92% | -169.70% | - | -3.97% | 5.98% | 14.70% |
Advertising Expenses | - | - | - | - | 0.27 | 0.26 |